Investors Reminded of Class Action Suit Against Blue Owl Capital Inc. with Critical Deadlines Ahead
Investor Alert: Class Action Lawsuit Against Blue Owl Capital Inc.
Pomerantz LLP has recently announced a pivotal class action lawsuit against Blue Owl Capital Inc. (NYSE: OWL), raising essential concerns for investors who have incurred losses related to their investments in the company. Those involved are urged to reach out to Danielle Peyton by email at [email protected], or via phone at 646-581-9980, toll-free at 888-4-POMLAW. Potential participants should provide their mailing address and the number of shares they acquired to facilitate the process.
The class action revolves around allegations that Blue Owl, along with certain officials and directors, may have engaged in securities fraud or other illegal business conduct. Investors affected have until February 2, 2025, to request the Court appoint them as Lead Plaintiff in the case, specifically if they purchased or otherwise acquired Blue Owl securities during the designated Class Period.
Recent Financial Performance and Market Impact
On October 30, 2025, Blue Owl disclosed its financial performance for the third quarter of the year, reporting fee-related earnings of only $376.2 million, a figure that fell short of market expectations. The fee-related earnings margin was reported at 57.1%, which was approximately 20 basis points lower than anticipated. Additionally, the firm noted a staggering decline of 33% in performance revenue compared to the previous year, amounting to only $188,000.
Following this disheartening news, Blue Owl’s share price experienced a notable drop of $0.70 per share, translating into a 4.23% decline, closing the day at $15.86.
Further repercussions were felt when, on November 5, two of Blue Owl's business development companies—Blue Owl Capital Corporation and Blue Owl Capital Corporation II—announced a definitive merger agreement. This sent stocks tumbling, with Blue Owl’s share prices dipping $0.74, or 4.72%, and settling at $14.95 on November 6, 2025.
This downward trajectory continued when, on November 16, 2025, an article from The Financial Times indicated that investors in BODCII might face substantial losses in connection with the merger and that current sentiments concerning private credit markets were deteriorating, leading to further declines. Blue Owl's stock price dropped again by $0.85, or 5.8%, ultimately reaching $13.77 per share on November 17, 2025.
Finally, on November 19, 2025, Blue Owl announced the cancellation of the proposed merger due to